Cleared Traditional

K240621 - Morpheus® Moldable (FDA 510(k) Clearance)

Also includes:
Agilon® Moldable
Apr 2024
Decision
56d
Days
Class 2
Risk

K240621 is an FDA 510(k) clearance for the Morpheus® Moldable. This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Biogennix, LLC (Irvine, US). The FDA issued a Cleared decision on April 30, 2024, 56 days after receiving the submission on March 5, 2024.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K240621 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2024
Decision Date April 30, 2024
Days to Decision 56 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV - Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045